Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shoji Oda is active.

Publication


Featured researches published by Shoji Oda.


Bioorganic & Medicinal Chemistry Letters | 2003

Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. Part 4: structure–activity relationships for substituents on the quinazoline moiety of 4-[4-(N-substituted(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives

Kenji Matsuno; Takashi Seishi; Takao Nakajima; Michio Ichimura; Neill A. Giese; Jin-Chen Yu; Shoji Oda; Yuji Nomoto

Here, we investigated the structure-activity relationships of the 6,7-dimethoxyquinazoline moiety. With regard to exploration of positions and varieties of substituents on the quinazoline ring, 6,7-dialkoxy substitution was optimal. This study suggests the possibility of further modifications for this moiety.


Archive | 1999

Nitrogenous heterocyclic compounds

Kenji Shimotogari Matsuno; Yuji Nakatogari Nagaizumi-cho Nomoto; Michio Ichimura; Shin-ich Ohoka Ide; Shoji Oda


Journal of Medicinal Chemistry | 2002

Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 1. Synthesis, structure-activity relationship, and biological effects of a new class of quinazoline derivatives.

Kenji Matsuno; Michio Ichimura; Takao Nakajima; Keiko Tahara; Shigeki Fujiwara; Hiroshi Kase; Junko Ushiki; Neill A. Giese; Anjali Pandey; Robert M. Scarborough; Nathalie Lokker; Jin-Chen Yu; Junko Irie; Eiji Tsukuda; Shinichi Ide; Shoji Oda; Yuji Nomoto


Journal of Medicinal Chemistry | 2003

Potent and Selective Inhibitors of Platelet-Derived Growth Factor Receptor Phosphorylation. 3. Replacement of Quinazoline Moiety and Improvement of Metabolic Polymorphism of 4-[4-(N-Substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline Derivatives

Kenji Matsuno; Junko Ushiki; Takashi Seishi; Michio Ichimura; Neill A. Giese; Jin-Chen Yu; Shusuke Takahashi; Shoji Oda; Yuji Nomoto


Journal of Pharmacology and Experimental Therapeutics | 2001

Efficacy of the Novel Selective Platelet-Derived Growth Factor Receptor Antagonist CT52923 on Cellular Proliferation, Migration, and Suppression of Neointima following Vascular Injury

Jin-Chen Yu; Nathalie Lokker; Stanley J. Hollenbach; Mutiah Apatira; Jason Li; Andreas Betz; David Sedlock; Shoji Oda; Yuji Nakatogari Nagaizumi-cho Nomoto; Kenji Shimotogari Matsuno; Shinichi Ide; Eiji Tsukuda; Neill A. Giese


Archive | 2000

1,3 diazines with platelet-derived growth factor receptor inhibitory activity

Kenji Matsuno; Michio Ichimura; Yuji Nomoto; Shigeki Fujiwara; Shinichi Ide; Eiji Tsukuda; Junko Irie; Shoji Oda


Archive | 2000

Nitrogen-containing heterocyclic compounds

Kenji Matsuno; Michio Ichimura; Yuji Nomoto; Shigeki Fujiwara; Shinichi Ide; Eiji Tsukuda; Junko Irie; Shoji Oda


Archive | 2001

Nitrogenous heterocylic compounds

Anjali Pandey; Robert M. Scarborough; Kenji Matsuno; Michio Ichimura; Yuji Nomoto; Shinichi Ide; Eiji Tsukuda; Junko Sasaki; Shoji Oda


Archive | 2001

Quinazolin-derivate als kinase inhibitoren

Anjali Pandey; Robert M. Scarborough; Kenji Matsuno; Michio Ichimura; Yuji Nomoto; Shinichi Ide; Eiji Tsukuda; Junko Irie; Shoji Oda


Archive | 2000

Peptides inhibiting vascular endothelial cell migration

Kenji Shibata; Motoo Yamasaki; Eiji Tsukuda; Shoji Oda; Kaoru Miyamoto

Collaboration


Dive into the Shoji Oda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eiji Tsukuda

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Shinichi Ide

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Junko Irie

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Anjali Pandey

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jin-Chen Yu

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Neill A. Giese

Millennium Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge